• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Sobi

Anonymous board for Sobi
Replies
13
Views
6K
anonymous
Replies
2
Views
1K
anonymous